Goldman Sachs analyst Robert Cox raised the firm’s price target on Arch Capital (ACGL) to $93 from $84 and keeps a Sell rating on the shares. In a sector note on Americas Insurance, the firm said it expects “strong and fairly resilient” insurer profitability for the next few years, but added that it believes we are “solidly in the softening phase” of the P&C insurance cycle, which leads to “increased capital supply and competition, which should drive a deceleration in growth/pricing/margins, that we think are broadly underappreciated within Street estimates.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACGL:
- Arch Capital price target raised to $100 from $97 at Evercore ISI
- Arch Capital price target raised to $117 from $111 at JPMorgan
- Arch Capital price target raised to $102 from $100 at Keefe Bruyette
- Arch Capital price target lowered to $131 from $135 at BofA
- Arch Capital initiated with a Neutral at Mizuho
